Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,527	3,348	2,186	2,286	3,039	1,383
Market Cap Growth	11.57%	53.13%	-4.36%	-24.78%	119.78%	-10.37%
Enterprise Value	3,117	2,980	1,756	2,063	2,601	1,110
PE Ratio	31.96	31.74	21.59	20.32	28.67	14.68
PS Ratio	6.74	6.94	5.44	6.25	8.59	4.51
PB Ratio	6.44	6.61	4.36	6.08	5.81	3.73
P/FCF Ratio	28.29	26.38	18.23	13.65	20.16	10.24
P/OCF Ratio	28.26	26.35	18.17	13.62	20.00	10.16
EV/Sales Ratio	5.95	6.18	4.37	5.64	7.35	3.62
EV/EBITDA Ratio	25.36	27.34	15.14	16.12	19.94	9.76
EV/EBIT Ratio	25.74	27.95	15.61	16.57	20.29	9.95
EV/FCF Ratio	24.99	23.48	14.64	12.32	17.26	8.22
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	0.00	0.00	0.01	0.00	0.02	0.03
Debt / FCF Ratio	0.00	0.00	0.01	0.00	0.02	0.03
Quick Ratio	4.86	3.92	6.38	5.28	9.83	7.62
Current Ratio	5.18	4.39	6.89	5.61	10.07	7.91
Asset Turnover	0.87	0.82	0.77	0.69	0.69	0.86
Return on Equity (ROE)	24.20%	22.00%	22.20%	23.10%	22.60%	29.20%
Return on Assets (ROA)	19.60%	17.90%	19.50%	21.10%	20.70%	26.40%
Return on Capital (ROIC)	18.59%	18.02%	19.54%	29.77%	19.64%	24.05%
Earnings Yield	3.32%	3.15%	4.63%	4.92%	3.49%	6.81%
FCF Yield	3.54%	3.79%	5.48%	7.32%	4.96%	9.76%
Buyback Yield / Dilution	4.77%	3.64%	7.94%	-1.42%	-1.33%	3.25%
Total Shareholder Return	4.77%	3.64%	7.94%	-1.42%	-1.33%	3.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).